B. Riley's Top Biotech Picks Ahead of 3Q26 Earnings Season

Investing.com -- B. Riley analyst Mayank Mamtani has identified top biotech picks heading into third-quarter 2026 earnings season, following the Federal Reserve's 25 basis point rate hike to 4.00%, its first increase since July 2023.
Read more...